PFF Registry News

 

Spotlight on the Impact of Precision Medicine in Clinical Trial Development

  • Jan 25, 2021 by ACRPtv

ACRPtv―Spotlight On… The Impact of Precision Medicine in Clinical Trial Development

ACRPtv

Dr. Kevin Flaherty, Chair, Pulmonary Fibrosis Foundation Registry, and Professor of Medicine at the University of Michigan

Featuring Dr. Kevin Flaherty, Chair, Pulmonary Fibrosis Foundation Registry, and Professor of Medicine at the University of Michigan.

In this January 22, 2021 interview, Flaherty discusses the first clinical trial to apply principles of precision medicine to the treatment of patients with idiopathic pulmonary fibrosis and how the trial overcame Covid-19-related obstacles to enroll its first patient this month.


Press Releases

July 18, 2022: Pulmonary Fibrosis Foundation launches community registry for self-reported data

July 18, 2022: Pulmonary Fibrosis Foundation Introduces Community Registry for Self-Reported Data: Participation Will Accelerate Medical Research Surrounding Life-Threatening Lung Disease

January 14, 2021:  Pulmonary Fibrosis Foundation Announces Sponsorship by United Therapeutics

January 11, 2021:  First Patient Enrolls In PRECISIONS Study For Treatment Of Idiopathic Pulmonary Fibrosis

March 4, 2020:  Pulmonary Fibrosis Foundation Launches Industry Consortium To Identify Biomarkers In Pulmonary Fibrosis

November 4, 2019:  NIH Awards Major Grant in Pulmonary Fibrosis Research

Donate Today

Your gift to the PFF Registry will enable us to expand patient enrollment and provide even greater access to investigators as they search for a cure for PF.

Your Privacy Matters

The Pulmonary Fibrosis Foundation Registry considers the protection of your privacy to be one of our most important responsibilities. We have set up strict protocols to protect your personal information. Review our privacy policy.

Contact Us

For information about the PFF Registry, contact registry@pulmonaryfibrosis.org.

PFF Registry

Patient Powered. Data Driven. Research Results.